Merrimack Pharmaceuticals Inc. (NASDAQ:MACK)’s President and Chief Executive Officer J. Robert Mulroy used some stock options on August 21st. to acquire…
Browsing: (NASDAQ:MACK)
After Merrimack Pharmaceuticals Inc. (NASDAQ:MACK)’s stock plummeted by over 10% yesterday, some insiders were clever and took advantage of the…